![QPS-logo-white-tagline](https://www.qps.com/wp-content/uploads/2019/05/QPS-logo-white-tagline-1024x458.webp)
QPS is proud to have taken part in a series of podcasts with Bioanalysis Zone called...
The New frontier: the bioanalysis of cell and gene therapies.
![Podcast-image-1](https://www.qps.com/wp-content/uploads/2024/05/Podcast-image-1-1024x536.webp)
In the first episode of the new frontier podcast, Kimberley Buytaert-Hoefen, Executive Director and Global Head of Regulatory Services at QPS, talks about her experience with cell and gene…
![Podcast-image-2](https://www.qps.com/wp-content/uploads/2024/05/Podcast-image-2-1024x536.webp)
In the second episode of ‘The new frontier’, Senior Director Johanna Morata talks about her experience with immunogenicity testing for cell and gene therapies (CGTs) and…
![Podcast-image-3](https://www.qps.com/wp-content/uploads/2024/05/Podcast-image-3-1024x536.webp)
In the third episode of The New Frontier podcast, Daniel Schulz-Jander, Senior Director of Mass spectrometry Bioanalysis at QPS Netherlands (Groningen) explains how he uses immune-precipitation and…
![Podcast-image-4](https://www.qps.com/wp-content/uploads/2024/05/Podcast-image-4-1024x536.webp)
In the fourth episode of The New Frontier podcast, Sebastian Guelman, Senior Principal Scientist for Bioanalytical Sciences from Genentech (CA, USA) talks about his experience with optimizing ddPCR assays to…
![Podccast-image-5](https://www.qps.com/wp-content/uploads/2024/05/Podccast-image-5-1024x536.webp)
In the fifth episode of The new frontier podcast, Paul Byrne, Senior Director of Genomics from ProtaGene (MA, USA) describes his experience working with qPCR…